Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Psychiatry Reports
Published in: Current Psychiatry Reports 1/2017

01-01-2017 | Bipolar Disorders (R Hirschfeld, Section Editor)

Treatment of Functional Impairment in Patients with Bipolar Disorder

Authors: Jose Sanchez-Moreno, Anabel Martinez-Aran, Eduard Vieta

Published in: Current Psychiatry Reports | Issue 1/2017

Login to get access

Abstract

Traditionally, functional impairment has received little attention in bipolar disorder, despite the fact that many patients experience significant impairments in daily life. In the last decade, research has changed its focus from clinical remission to functional recovery in bipolar patients as a priority. A literature review of this topic will allow us provide an overview of the relevance of functional impairment as well as the potential factors that can predict or contribute to low functioning in bipolar disorder (BD). Treatment approaches should consider not only euthymia as a goal but also cognitive and functional improvement of patients with such a complex disorder. Functional remediation and psychoeducation among psychological interventions may help to enhance functioning. The combination of cognitive enhancers and cognitive/functional remediation programs may help in improving cognitive and functional impairments. Early interventions are essential to prevent cognitive deficits and disability.
Literature
1.
Catalá-López F, Gènova-Maleras R, Vieta E, Tabarés-Seisdedos R. The increasing burden of mental and neurological disorders. Eur Neuropsychopharmacol. 2013;23(11):1337–9.CrossRefPubMed
2.
Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241–51.CrossRefPubMedPubMedCentral
3.
Rosa AR, Franco C, Martínez-Aran A, Sánchez-Moreno J, Reinares M, Salamero M, et al. Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom. 2008;77(6):390–2.CrossRefPubMed
4.
Rosa AR, Reinares M, Franco C, Comes M, Torrent C, Sánchez-Moreno J, et al. Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord. 2009;11(4):401–9.CrossRefPubMed
5.
Bonnin CM, Sanchez-Moreno J, Martinez-Aran A, Sole B, Reinares M, Rosa AR, et al. Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord. 2012;136(3):650–59.CrossRefPubMed
6.
•• Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561–72. Current knowledge about research and future directions on bipolar disorder.CrossRefPubMed
7.
8.
Rosa AR, Reinares M, Amann B, Popovic D, Franco C, Comes M, et al. Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program. Bipolar Disord. 2011;13(7–8):679–86.CrossRefPubMed
9.
Rosa AR, Reinares M, Michalak EE, Bonnin CM, Sole B, Franco C, et al. Functional impairment and disability across mood states in bipolar disorder. Value Health. 2010;13(8):984–8.CrossRefPubMed
10.
Moreno C, Hasin DS, Arango C, Oquendo MA, Vieta E, Liu S, et al. Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord. 2012;14(3):271–82.CrossRefPubMedPubMedCentral
11.
van der Voort TY, Seldenrijk A, van Meijel B, Goossens PJ, Beekman AT, Penninx BW, et al. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder. J Clin Psychiatry. 2015;76(6):e809–14.CrossRefPubMed
12.
Alonso J, Petukhova M, Vilagut G, Chatterji S, Heeringa S, Üstün TB, et al. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol Psychiatry. 2011;16(12):1234–4.CrossRefPubMed
13.
Grande I, Goikolea JM, de Dios C, González-Pinto A, Montes JM, Saiz-Ruiz J, et al. Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data). Acta Psychiatr Scand. 2013;127(5):403–11.CrossRefPubMed
14.
Zarate Jr CA, Tohen M, Land M, Cavanagh S. Functional impairment and cognition in bipolar disorder. Psychiatr Q. 2000;71(4):309–29.CrossRefPubMed
15.
Sanchez-Moreno J, Martinez-Aran A, Tabarés-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78(5):285–97.CrossRefPubMed
16.
Rosa AR, González-Ortega I, González-Pinto A, Echeburúa E, Comes M, Martínez-Àran A, et al. One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand. 2012;125(4):335–41.CrossRefPubMed
17.
Tohen M, Zarate Jr CA, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003;160(12):2099–107.CrossRefPubMed
18.
Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001;67(1–3):45–59.CrossRefPubMed
19.
Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E, EMBLEM Advisory Board. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord. 2007;9(1–2):45–52.CrossRefPubMed
20.
Vieta E. The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatr Scand. 2014;129(5):323–7.CrossRefPubMed
21.
• Reinares M, Papachristou E, Harvey P, et al. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord. 2013;144(1–2):65–71. This study shows the first empirically derived staging classification of bipolar disorder based on illness severity and cognitive function dimensions.CrossRefPubMed
22.
Bonnin CM, Martinez-Aran A, Torrent C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121(1–2):156–60.CrossRefPubMed
23.
Bowie CR, Depp C, McGrath JA, Wolyniec P, Mausbach BT, Thornquist MH, et al. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry. 2010;167(9):1116–24.CrossRefPubMedPubMedCentral
24.
Strejilevich SA, Martino DJ, Murru A, Teitelbaum J, Fassi G, Marengo E, et al. Mood instability and functional recovery in bipolar disorders. Acta Psychiatr Scand. 2013;128(3):194–202.CrossRefPubMed
25.
•• Bonnin CM, Gonzalez-Pinto A, Sole B, Reinares M, Gonzalez-Ortega I, Alberich S, et al. Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder. J Affect Disord. 2014;160:50–4. This study demonstrates the role of verbal memory as a mediator of the relationship of subthreshold symptoms predicting the functional outcome.CrossRef
26.
Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 2007;9(1–2):183–96.CrossRefPubMed
27.
Sanchez-Moreno J, Martinez-Aran A, Gadelrab HF, Cabello M, Torrent C, Bonnin Cdel M, et al. The role and impact of contextual factors on functioning in patients with bipolar disorder. Disabil Rehabil. 2010;32 Suppl 1:S94–S104.CrossRefPubMed
28.
Gyulai L, Bauer MS, Marangell LB, Dennehy EB, Thase ME, Otto MW, et al. Correlates of functioning in bipolar disorder. Psychopharmacol Bull. 2008;41(4):51–64.PubMed
29.
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009;11(5):453–73.CrossRefPubMed
30.
•• Gade K, Malzahn D, Anderson-Schmidt H, Strohmaier J, Meier S, Frank J, et al. Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: a potential cross-diagnostic phenotype for further genetic investigations? World J Biol Psychiatry. 2015;16(4):237–48. This study demonstrates the relevance of functional outcome in major psychiatric disorders.CrossRefPubMed
31.
Martinez-Aran A, Vieta E. Cognition as a target in schizophrenia, bipolar disorder and depression. Eur Neuropsychopharmacol. 2015;25(2):151–7.CrossRefPubMed
32.
•• Moore RC, Harmell AL, Harvey PD, Bowie CR, Depp CA, Pulver AE, et al. Improving the understanding of the link between cognition and functional capacity in schizophrenia and bipolar disorder. Schizophr Res. 2015;169(1–3):121–7. This study demonstrates the complex relationship between cognitive and functional impairments in schizophrenia and bipolar disorder.CrossRefPubMedPubMedCentral
33.
Martínez-Arán A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6:224–32.CrossRefPubMed
34.
Martinez-Aran A, Vieta E, Torrent C, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1–2):103–13.CrossRefPubMed
35.
Martino DJ, Strejilevich SA, Scápola M, Igoa A, Marengo E, Ais ED, et al. Heterogeneity in cognitive functioning among patients with bipolar disorder. J Affect Disord. 2008;109(1–2):149–56.CrossRefPubMed
36.
Forcada I, Papachristou E, Mur M, Christodoulou T, Jogia J, Reichenberg A, et al. The impact of general intellectual ability and white matter volume on the functional outcome of patients with Bipolar Disorder and their relatives. J Affect Disord. 2011;130(3):413–20.CrossRefPubMed
37.
•• Forcada I, Mur M, Mora E, Vieta E, Bartrés-Faz D, Portella MJ. The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur Neuropsychopharmacol. 2015;25(2):214–22. This study demonstrates the relevance of cognitive reserve on the functional outcome in bipolar disorder.CrossRefPubMed
38.
•• Anaya C, Torrent C, Caballero FF, Vieta E, Bonnin CD, Ayuso-Mateos JL. Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life. Acta Psychiatr Scand. 2016;133(5):386–98. This study demonstrates the relationship between cognitive reserve, cognitive impairment and functional outcome in bipolar disorder.CrossRefPubMed
39.
Arbuckle R, Frye MA, Brecher M, Paulsson B, Rajagopalan K, Palmer S, et al. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder. Psychiatry Res. 2009;165(1–2):163–74.CrossRefPubMed
40.
Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.CrossRefPubMedPubMedCentral
41.
Mausbach BT, Harvey PD, Goldman SR, Jeste DV, Patterson TL. Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull. 2007;33(6):1364–72.CrossRefPubMedPubMedCentral
42.
Ghaemi SN, Gilmer WS, Dunn RT, Hanlon RE, Kemp DE, Bauer AD, et al. A double-blind, placebo- controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder. J Clin Psychopharmacol. 2009;29(3):291–5.CrossRefPubMed
43.
•• Sanches M, Bauer IE, Galvez JF, Zunta-Soares GB, Soares JC. The management of cognitive impairment in bipolar disorder: current status and perspectives. Am J Ther. 2015;22(6):477–86. This study reviews mainly the pharmacological treatments for cognitive impairment in bipolar disorder.CrossRefPubMedPubMedCentral
44.
Burdick KE, Braga RJ, Nnadi CU, Shaya Y, Stearns WH, Malhotra AK. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J Clin Psychiatry. 2012;73(1):103–12.CrossRefPubMed
45.
Miskowiak KW, Vinberg M, Glerup L, Paulson OB, Knudsen GM, Ehrenreich H, et al. Neural correlates of improved executive function following erythropoietin treatment in mood disorders. Psychol Med. 2016;46(8):1679–91.CrossRefPubMed
46.
• Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, et al. Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol. 2015;25(2):257–64. This study demonstrates the efficacy of functional remediation in patients with bipolar II disorder at improving functioning.CrossRefPubMed
47.
• Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials. BMC Psychiatry. 2016;16:157. This study demonstrates improvements in functioning of patients with bipolar depression treated with lurasidone.CrossRefPubMedPubMedCentral
48.
McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014;17(10):1557–67.CrossRefPubMedPubMedCentral
49.
Anaya C, Martinez Aran A, Ayuso-Mateos JL, Wykes T, Vieta E, Scott J. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord. 2012;142(1–3):13–2.CrossRefPubMed
50.
Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry. 2003;60(4):402–7.CrossRefPubMed
51.
Bonnin CM, Torrent C, Vieta E, Martínez-Arán A. Restoring functioning in bipolar disorder: functional remediation. Harv Rev Psychiatry. 2014;22(6):326–30.CrossRefPubMed
52.
Deckersbach T, Nierenberg AA, Kessler R, et al. Cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010;16:298–307.CrossRefPubMedPubMedCentral
53.
Martínez-Arán A, Torrent C, Solé B, Bonnín CM, Rosa AR, Sánchez-Moreno J, et al. Functional remediation for bipolar disorder. Clin Pract Epidemiol Ment Health. 2011;7:112–6.CrossRefPubMedPubMedCentral
54.
•• Torrent C, Bonnin Cdel M, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170(8):852–9. This study demonstrates the efficacy of a novel adjunctive intervention for bipolar disorder patients with low functioning.CrossRefPubMed
55.
•• Bonnin CM, Torrent C, Arango C, Amann BL, Solé B, González-Pinto A, et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. Br J Psychiatry. 2016;208(1):87–93. This a 1-year follow-up of the previous study showing the maintenance of duration of effects of functional remediation on psychosocial functioning.CrossRefPubMed
56.
Solé B, Jiménez E, Martinez-Aran A, Vieta E. Cognition as a target in major depression: new developments. Eur Neuropsychopharmacol. 2015;25(2):231–47.CrossRefPubMed
57.
Demant KM, Vinberg M, Kessing LV, Miskowiak KW. Assessment of subjective and objective cognitive function in bipolar disorder: correlations, predictors and the relation to psychosocial function. Psychiatry Res. 2015;229(1–2):565–71.CrossRefPubMed
58.
Zyto S, Jabben N, Schulte PF, Regeer BJ, Kupka RW. A pilot study of a combined group and individual functional remediation program for patients with bipolar I disorder. J Affect Disord. 2016;194:9–15.CrossRefPubMed
59.
Lewandowski KE, Sperry SH, Ongur D, Cohen BM, Norris LA, Keshavan MS. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial. Trials. 2016;17(1):136.CrossRefPubMedPubMedCentral
60.
Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, et al. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv. 2006;57(7):927–36.CrossRefPubMed
61.
Greer TL, Grannemann BD, Chansard M, Karim A, Trivedi MH. Dose-dependent changes in cognitive function with exercise augmentation for major depression: results from the TREAD study. Eur Neuropsychopharmacol. 2015;25(2):248–56.CrossRefPubMed
62.
Breitborde NJ, Dawson SC, Woolverton C, Dawley D, Bell EK, Norman K, et al. A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder. BMC Psychol. 2014;2(1):41.CrossRefPubMedPubMedCentral
63.
•• Cella M, Reeder C, Wykes T. Group cognitive remediation for schizophrenia: exploring the role of therapist support and metacognition. Psychol Psychother. 2016;89(1):1–14. This study demonstrates the key role of metacognition for cognitive remediation.CrossRefPubMed
Metadata
Title
Treatment of Functional Impairment in Patients with Bipolar Disorder
Authors
Jose Sanchez-Moreno
Anabel Martinez-Aran
Eduard Vieta
Publication date
01-01-2017
Publisher
Springer US
Published in
Current Psychiatry Reports / Issue 1/2017
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-017-0752-3

Other articles of this Issue 1/2017

Current Psychiatry Reports 1/2017 Go to the issue

Personality Disorders (C Schmahl, Section Editor)

Dissociation and Alterations in Brain Function and Structure: Implications for Borderline Personality Disorder

Attention-Deficit Disorder (A Rostain, Section Editor)

Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016

Attention-Deficit Disorder (A Rostain, Section Editor)

Prenatal Risk Factors and the Etiology of ADHD—Review of Existing Evidence

Bipolar Disorders (R Hirschfeld, Section Editor)

Use of Stimulants in Bipolar Disorder

Schizophrenia and Other Psychotic Disorders (SJ Siegel, Section Editor)

Schizophrenia: Impact on Family Dynamics

Substance Use and Related Disorders (F Levin and E Dakwar, Section Editors)

Treating Mental Health and Substance Use Disorders in Adolescents: What Is on the Menu?